From: Trends in utilization and costs of migraine medications, 2017–2020
Migraine-related drug users | 2017 | 2018 | 2019 | 2020 | 4-year trend | ||
---|---|---|---|---|---|---|---|
% | p-value | ||||||
Overall | $128.41 | $104.37 | $102.37 | $112.01 | -12.8% | < 0.001 | |
Antidepressants | Prophylaxis | $15.38 | $13.67 | $12.11 | $11.44 | -25.6% | < 0.001 |
Anticonvulsants | Prophylaxis | $39.91 | $45.10 | $42.58 | $43.82 | 9.8% | < 0.001 |
Beta blockers | Prophylaxis | $22.01 | $18.35 | $14.65 | $13.40 | -39.1% | < 0.001 |
ACEI/ARB | Prophylaxis | $5.76 | $5.55 | $5.11 | $4.69 | -18.5% | < 0.001 |
CGRP mABs | Prophylaxis | $109.35 | $243.06 | $291.17 | |||
Triptans | Treatment | $65.96 | $49.36 | $38.28 | $31.92 | -51.6% | < 0.001 |
Chronic opioids | Treatment | $91.47 | $69.81 | $64.32 | $64.92 | -29.0% | < 0.001 |
NSAIDs and non-narcotic analgesics | Treatment | $45.34 | $37.90 | $30.96 | $23.90 | -47.3% | < 0.001 |
Ergotamine | Treatment | $850.56 | $788.94 | $820.91 | $761.99 | -10.4% | 0.665 |
Barbiturates | Treatment | $32.85 | $29.65 | $23.64 | $21.83 | -33.6% | 0.845 |
Isometheptene | Treatment | $46.60 | $35.93 | $15.11 | |||
Gepants | Treatment | $177.63 | |||||
Ditans | Treatment | $86.83 | |||||
Other treatment classesa | Treatment | $99.72 | $98.85 | $95.47 | $84.37 | -15.4% | < 0.001 |